Oncotarget

Meta-Analysis:

High pretreatment plasma D-dimer predicts poor survival of colorectal cancer: insight from a meta-analysis of observational studies

Shao-Long Lu, Zhi-Hua Ye, Tong Ling, Si-Yuan Liang, Hui Li, Xiao-Zhun Tang, Yan-Song Xu and Wei-Zhong Tang _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:81186-81194. https://doi.org/10.18632/oncotarget.20919

Metrics: PDF 1053 views  |   HTML 1645 views  |   ?  


Abstract

Shao-Long Lu1, Zhi-Hua Ye1, Tong Ling1, Si-Yuan Liang1, Hui Li1, Xiao-Zhun Tang2, Yan-Song Xu2 and Wei-Zhong Tang1

1Department of Colorectal Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P. R. China

2Department of Emergency, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, P. R. China

Correspondence to:

Wei-Zhong Tang, email: tangweizhong0771@163.com

Keywords: D-dimer, prognosis, colorectal cancer

Received: June 16, 2017     Accepted: August 26, 2017     Published: September 15, 2017

ABSTRACT

D-dimer, one of the canonical markers of hypercoagulability, was reported to be a potential prognostic marker of colorectal cancer. However, an inconsistent conclusion existed in several published studies. Thus, we performed this meta-analysis to provide a comprehensive insight into the prognostic role for pretreatment D-dimer in colorectal cancer. Six databases (English: Pubmed, Embase and Web of Science; Chinese: CNKI, Wangfang and VIP) were utilized for the literature retrieval. Hazard ratio (HR) was pooled by Stata 12.0. A total of fifteen studies (2283 cases) corresponded to this meta-analysis and provided available data to evaluate the prognostic role of D-dimer for colorectal cancer. The pooled HR reached 2.167 (95%. CI (confidence interval): 1.672–2.809, P < 0.001) utilizing random effect model due to obvious heterogeneity among the included studies (I2: 73.3%; P < 0.001). To explore the heterogeneity among the studies, we conducted a sensitivity analysis and found a heterogeneous study. After removing it, the heterogeneity reduced substantially (I2: 0%; P = 0.549) and we obtained a more convincing result by fixed effect model (HR = 2.143, 95% CI = 1.922–2.390, P < 0.001, 14 studies with 2179 cases). In summary, high pretreatment plasma D-dimer predicts poor survival of colorectal cancer based on the current evidence. Further prospective researches are necessary to confirm the role of D-dimer in colorectal cancer.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 20919